Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? Yes
Write-up: This case was reported by an unknown physician via a regulatory authority and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). It was unknown whether or not the subject experienced any adverse event post previous vaccination(s). On 14 July 2008 the subject received an unspecified dose of ROTARIX (0.5 ml, oral). Approximately three days post vaccination with ROTARIX, on 17 July 2008, the subject experienced invagination of intestine. The subject was hospitalised for an unknown period of time. The reporting physician considered that the event was life threatening. Treatment included hydrostatic disinvagination on 17 July 2008 without success. On 18 July 2008 the subject underwent bowel surgery. The reporting physician considered undesirable vaccination adverse reaction. At the time of reporting, on 08 August 2008, the events were resolved with the following sequelae (state post surgery). No further information will be available.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166